Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response (vol 53, pg 237, 2024)

被引：0
|
作者：
Mathew, A. J.
Hetland, M. L.
Pedersen, M. P.
Rasmussen, S. H.
Glintborg, B.
Loft, A. G.
Nissen, M. J.
Moller, B.
Rodrigues, A. M.
Santos, F. P.
Rotar, Z.
Tomsic, M.
Relas, H.
Peltomaa, R.
Gudbjornsson, B.
Love, T. J.
Kocaer, S. B.
Avsar, A. Koken
Midtboll Ornbjerg, L.
Ostergaard, M.
机构：
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2024年 / 53卷 / 05期
关键词：
D O I：
10.1080/03009742.2024.2377498
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：368 / 368
页数：1
相关论文
共 34 条
  • [21] PATIENT-REPORTED OUTCOMES FROM A PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS
    Smolen, J. S.
    Kremer, J.
    Gaich, C.
    DeLozier, A. M.
    Schlichting, D.
    Xie, L.
    Genovese, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 785 - 786
  • [22] SEX DIFFERENCES IN PATIENT-REPORTED OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS: RESULTS FROM A MULTINATIONAL OBSERVATIONAL COHORT STUDY
    Hellamand, P.
    de Sande, M. G. H. Van
    Nurmohamed, M. T.
    Van Vollenhoven, R.
    Hollick, R.
    Rotariu, O.
    Rotar, Z.
    Pirkmajer, K.
    Nordstrom, D.
    Hokkanen, A. M.
    Michelsen, B.
    Kvien, T. K.
    Glintborg, B.
    Loft, A. G.
    Pavelka, K.
    Zavada, J.
    Castrejon, I.
    Otero-Varela, L.
    Gudbjornsson, B.
    Palsson, O.
    Ostergaard, M.
    Hetland, M. L.
    Wallman, J. K.
    Di Giuseppe, D.
    Ciurea, A.
    Nissen, M. J.
    Yildirim, T. Demirci
    Onen, F.
    Codreanu, C.
    Mogosan, C.
    Santos, M. J.
    Vieira-Sousa, E.
    Iannone, F.
    Lapadula, G.
    Ornbjerg, L. Midtboll
    Twisk, J.
    Van der Horst-Bruinsma, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 360 - 361
  • [23] Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
    Gossec, Laure
    Siebert, Stefan
    Bergmans, Paul
    de Vlam, Kurt
    Gremese, Elisa
    Joven-Ibanez, Beatriz
    Korotaeva, Tatiana V.
    Lavie, Frederic
    Noel, Wim
    Nurmohamed, Michael T.
    Sfikakis, Petros P.
    Sharaf, Mohamed
    Theander, Elke
    Smolen, Josef S.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [24] Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
    Laure Gossec
    Stefan Siebert
    Paul Bergmans
    Kurt de Vlam
    Elisa Gremese
    Beatríz Joven-Ibáñez
    Tatiana V. Korotaeva
    Frederic Lavie
    Wim Noël
    Michael T. Nurmohamed
    Petros P. Sfikakis
    Mohamed Sharaf
    Elke Theander
    Josef S. Smolen
    Arthritis Research & Therapy, 25
  • [25] Guselkumab Provides Clinically Meaningful Improvents in Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis Who Are Inadequate Responders to Tumour Necrosis Factor Inhibitors: Results Through One Year of a Phase 3b, Randomized, Controlled Study (COSMOS)
    Gossec, Laure
    Baraliakos, Xenofon
    Galloway, James
    Erik, Lars
    Oke, Vilija
    Sfikakis, Petros
    Rampakakis, Emmanouil
    Sharaf, Mohamed
    Lavie, Frederic
    McInnes, Iain
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2807 - 2809
  • [26] PAIN AND OTHER PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO DID OR DID NOT ACHIEVE TREATMENT RESPONSE BASED ON IMPROVEMENT IN SWOLLEN JOINTS IN TOCILIZUMAB CLINICAL TRIALS
    Sebba, A.
    Han, J.
    Mohan, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 990 - 991
  • [27] Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in Tocilizumab Clinical Trials
    Sebba, Anthony
    Han, Jian
    Mohan, Shalini V.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [28] Correlation Between Objective and Patient Self-Reported Clinical Improvement After Multiple Courses of Rituximab in Rheumatoid Arthritis Patients With Inadequate Response to Tumour Necrosis Factor Inhibitors: Data From Repeat Study
    Ancuta, Ioan
    Codreanu, Catalin
    Ionescu, Ruxandra
    Parvu, Magda
    Nemes, Dan
    Chirieac, Rodica
    Ciurea, Paulina
    Suta, Maria
    Balanescu, Andra
    Mociran, Eugenia
    Rezus, Elena
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S185 - S185
  • [29] CORRELATION BETWEEN OBJECTIVE AND PATIENT SELF-REPORTED CLINICAL IMPROVEMENT AFTER MULTIPLE COURSES OF RITUXIMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: DATA FROM REPEAT STUDY
    Ancuta, I.
    Codreanu, C.
    Ionescu, R.
    Nemes, D.
    Chirieac, R.
    Paulina, C.
    Suta, M.
    Balanescu, A.
    Mociran, E.
    Rezus, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 454 - 455
  • [30] Patient-Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Kavanaugh, Arthur
    McInnes, Iain B.
    Krueger, Gerald G.
    Gladman, Dafna
    Beutler, Anna
    Gathany, Tim
    Mack, Michael
    Tandon, Neeta
    Han, Chenglong
    Mease, Philip
    ARTHRITIS CARE & RESEARCH, 2013, 65 (10) : 1666 - 1673
1234